Advertisement
UK markets close in 5 hours 47 minutes
  • FTSE 100

    8,298.49
    +85.00 (+1.03%)
     
  • FTSE 250

    20,389.43
    +224.89 (+1.12%)
     
  • AIM

    777.03
    +5.50 (+0.71%)
     
  • GBP/EUR

    1.1657
    -0.0002 (-0.02%)
     
  • GBP/USD

    1.2542
    -0.0022 (-0.18%)
     
  • Bitcoin GBP

    51,212.14
    -747.01 (-1.44%)
     
  • CMC Crypto 200

    1,333.77
    -31.36 (-2.30%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CRUDE OIL

    78.56
    +0.08 (+0.10%)
     
  • GOLD FUTURES

    2,324.30
    -6.90 (-0.30%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,290.92
    +115.71 (+0.64%)
     
  • CAC 40

    8,023.35
    +26.71 (+0.33%)
     

Compared to Estimates, Centene (CNC) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2024, Centene (CNC) reported revenue of $40.41 billion, up 3.9% over the same period last year. EPS came in at $2.26, compared to $2.11 in the year-ago quarter.

The reported revenue represents a surprise of +10.97% over the Zacks Consensus Estimate of $36.41 billion. With the consensus EPS estimate being $2.09, the EPS surprise was +8.13%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how Centene performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Total Medical Health (Benefits) loss Ratios -Total Ratio (HBR): 87.1% versus the five-analyst average estimate of 87.1%.

  • Membership Medicaid - High Acuity Medicaid: 1,547.6 thousand versus the three-analyst average estimate of 1,737.68 thousand.

  • Membership by line of business - Medicaid: 13,297.6 thousand versus 13,589.05 thousand estimated by three analysts on average.

  • SG&A Expense Ratio: 8.9% versus 8.7% estimated by three analysts on average.

  • Revenues- Premium and service revenues: $36.34 billion versus the five-analyst average estimate of $34.07 billion. The reported number represents a year-over-year change of +4%.

  • Revenues- Premium: $35.53 billion versus $33.07 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +5% change.

  • Revenues- Service: $808 million versus the five-analyst average estimate of $993.85 million. The reported number represents a year-over-year change of -28.3%.

  • Revenues- Premium tax: $4.07 billion versus the five-analyst average estimate of $2.52 billion.

  • Revenues- Premium and service revenues- Commercial: $7.75 billion versus $7.89 billion estimated by three analysts on average.

  • Revenues- Premium and service revenues- Medicare: $5.94 billion compared to the $5.31 billion average estimate based on three analysts.

  • Revenues- Premium and service revenues- Medicaid: $21.46 billion versus the three-analyst average estimate of $20.75 billion. The reported number represents a year-over-year change of -3.5%.

  • Revenues- Premium and service revenues- Other: $1.19 billion versus the two-analyst average estimate of $1.42 billion. The reported number represents a year-over-year change of -25.4%.

View all Key Company Metrics for Centene here>>>

Shares of Centene have returned -3.6% over the past month versus the Zacks S&P 500 composite's -3.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Centene Corporation (CNC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research